-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - unknown, but the disorder
also occurs secondary to other conditions such as iron
deficiency, end-stage renal … time since
diagnosis), baseline RLS symptom severity and
frequency, iron, pregnancy, and end-stage renal … psychiatric disorders,
substance abuse disorders, or other serious medical
conditions, including renal … • No eligible studies enrolled individuals with end-stage
renal disease, and almost all specifically … We identified
one other study in adults with RLS believed secondary to
end-stage renal disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
August 01, 2013 - The HAS-BLED scale (Hypertension, Abnormal renal/
liver function, Stroke, Bleeding history or predisposition … risk scores of interest due to unavailable
data, such as genetic factors in HEMORR2HAGES
(Hepatic or renal … Patients with renal impairment,
with different INR control, and with prior stroke seem
to benefit equally … large differences
between demographics of study populations and
community patients in terms of age, renal … Food and Drug Administration
GWTG Get With The Guidelines
HAS-BLED Hypertension, Abnormal renal/liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/home-dialysis-ESKD-rapid-research.pdf
April 01, 2025 - currently affects more than 800,000 Americans,
approximately 70 percent of whom are treated with renal … End stage renal disease and Medicare.
Health Care Financ Rev. 2003; 24(4):1-5. PMID
14628396.
3. … The early history of dialysis for
chronic renal failure in the United States: a view
from Seattle. … Screening
and supportive techniques for home dialysis in
the treatment of renal failure. … Patients’
preferences regarding choice of end-stage renal
disease treatment options.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
February 23, 2012 - Published Online: February 23, 2012
3
Pneumonia, including pneumococcal vaccination
End-stage renal … coronary
syndrome]; asthma, major depressive disorder asthma, cystic fibrosis, pneumonia,
and end-stage renal … Asthma
Cystic fibrosis
Pneumonia including pneumococcal vaccination
End-stage renal … depressive
disorder; asthma; cystic fibrosis; pneumonia including pneumococcal vaccination; and end stage renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_disposition-comments.pdf
August 23, 2012 - evaluation for a variety of symptoms and
laboratory abnormalities such as anemia, hypercalcemia, or
renal … An increased FLC ratio without IgH positivity
may also be associated with renal disorders and therefore … that 23% of patients
with an increased FLC ratio without IgH positivity either have
or will develop renal … as for MGUS) further workup with
bone marrow examination with clonality testing, imaging
studies, renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0316_03-12-2009.pdf
January 01, 2009 - , income
level, race/ethnicity, and clinical subgroups (e.g., hypertensive/normotensive, diabetic, renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
January 01, 2011 - amputation
2
People with diabetes often experience sev-
eral associated medical complications,
such as renal … The latter set of ICD-9 codes
represents the following microvascular diseases: diabetic
renal disease … Nontraumatic lower extremity amputations
in the Medicare end-stage renal disease population.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
November 20, 2013 - Rev 3 disc The decision to emphasize BMI and renal function as
potential confounders of the diagnostic … The AHRQ report in 2006 identified both renal function
and weight as potential physiological variables … high sensitivity C-reactive protein, N-
terminal proBNP, and cardiac troponin T and I in end stage
renal … If key
data such as heart rhythm, body mass and renal function
are not included then the model is not … Should be more
emphasis on the key importance of heart rhythm along with
adiposity and renal function
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
July 26, 2012 - direct patient-centered outcome is clinically
meaningful kidney damage (e.g. incident end
stage renal … disease, progression to stage 4
CKD or worse, developing of acute renal
failure requiring hospitalization … incident end stage renal disease, progression
to stage 4 CKD or worse, developing of acute
renal failure … Peer Reviewer
#3
Discussion Using acute renal failure or end stage renal disease as
outcomes is impractical … We
do not know what causes stones to become detached and/or to
pass and most non-obstructing renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - and consider dose reduction; limit to 10 mg once daily
when used in combination with gemfibrozil
• Renal … insufficiency statement: Rosuvastatin exposure is not influenced
by mild to moderate renal impairment … , exposure to rosuvastatin
is increased to a clinically significant extent in patients with severe renal … Please
edit to reflect dosage adjustment is in patients with severe renal
impairment. … Such patients are frail elderly, with
small body size, and diminished renal and hepatic function.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - These data are consistent with the biologic’s indications for advanced renal
cell carcinoma and hepatocellular … malignancy of
other and unspecified sites (190.x to 199.x), indicative of their labeled use
in advanced renal … Clearly, these biologics’ off-label use in renal cell carcinoma,
chronic myelogenous leukemia, and metastatic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - Modulates hyperactive glutamatergic
n-methyl-d-aspartate receptors
Anxiety
Diarrhea
Vomiting
Severe renal … a Dose adjustment for moderate renal impairment.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
December 20, 2011 - and the potential influences of confounders such as age,
ethnicity, and comorbidities (including renal … coronary artery disease (CAD), with CAD, other
adults at risk of HF without documented HF (diabetes, renal … has been used to
include or exclude subjects (e.g., acute coronary syndrome (ACS), CAD, Diabetes, Renal … hematocrit, widened QRS interval on 12-lead electrocardiogram, chronic hypotension, resting
tachycardia, renal … widened QRS
interval on 12-lead electrocardiogram, chronic hypotension, resting tachycardia, and
renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
May 29, 2025 - Reduced"effect"of"percutaneous"
renal"denervation"on"blood"pressure"in"patients"with"isolated"systolic"hypertension … Blood"pressure"changes"after"renal"denervation"at"10"European"expert"
centers." … "(2015)."4a.03:"Catheter'
Based"Renal"Denervation"for"Resistant"Hypertension:"24"Month"Results"of"the"Enlightn"I … Eligibility"for"percutaneous"
renal"denervation:"the"importance"of"a"systematic"screening." … Clinical(Outcomes(
SOE:(Insufficient(
(
One$quality$C$study$reported$
on$mortality$and$end"stage$
renal
-
effectivehealthcare.ahrq.gov/sites/default/files/reporting.ppt
September 01, 2009 - Example:
Randomized clinical trials studying the administration of hepatitis B vaccine to CRF [chronic renal … …Renal transplant patients were excluded from this review.
Schroth RJ, et al. … Hepatitis B vaccination for patients with chromic renal failure. … Hepatitis B vaccination for patients with chromic renal failure. … Hepatitis B vaccination for patients with chromic renal failure.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
March 15, 2016 - Renal stones were within scope, but no
placebo-controlled treatment RCTs
reported on this outcome. … We have modified the text on use in renal
impairment. … ,
patients taking either febuxostat or allopurinol with mild renal impairment achieved
higher rates … disease, and of intervening upon
hyperuricemia demonstrating renal benefits. … However, we did examine our
included studies for renal outcomes and
added these to the text.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
November 01, 2016 - regulation; medication adherence;
or self-monitoring for diabetic complications (foot exam,
eye exam, and renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
May 01, 2011 - Serious adverse events such as myocardial infarction, stroke,
and renal failure were either rarely reported
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
January 01, 2013 - medications,
nonsignificant results were observed for
withdrawal due to adverse events,
bleeding, renal … No statistically significant
effects were observed in withdrawal due
to adverse events, bleeding, renal … controlled or absent
cholesterolemia and
hypertension; no hx of
diabetes, CVD,
intervention, or renal … Adverse effects: No significant
change in hepatic, thyroid, renal, or
hematologic function. … No statistically significant effects were
observed in withdrawal due to adverse events, bleeding, renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
January 01, 2007 - For instance, biguanides such as
metformin are contraindicated in patients with renal or
liver failure … factors (e.g.,
race/ethnicity, age greater than 65 years, or gender)
or comorbid conditions (e.g., renal … did not have
enough information on subjects taking metformin with
chronic conditions such as chronic renal … areas to focus on would be effects of
medications in the elderly and in subjects with and
without renal … based on demographic factors (e.g., race/ethnicity, age >65 years, or
gender) or comorbidities (e.g., renal